|Articles|May 25, 2022
From development to GMP production in 100 days
Author(s)Curia
Antibodies and proteins are critical reagents with wide application in in vitro diagnostic developments, companion diagnostic and biomarker assays. Depending on final application, different quality standards may apply, from research use to full GMP production. Learn more about Curia’s GMP Production of antibodies & proteins for critical assays and diagnostic applications.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FDA Deploys Agentic AI Capabilities for Agency Staff
2
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
3
Live Cell High-Content Imaging Is Driving Drug Discovery
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5
